VF
LABU icon

Virtu Financial’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Virtu Financial’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,769
Closed -$1.76M – 1965
2025
Q3 		$1.76M Buy
+18,769
New +$1.33M 0.1% 198
2025
Q1 		– Sell
-33,807
Closed -$3.04M – 1713
2024
Q4 		$3.04M Buy
+33,807
New +$3.98M 0.16% 105
2023
Q2 		– Sell
-14,980
Closed -$1.47M – 1778
2023
Q1 		$1.47M Buy
+14,980
New +$2.03M 0.16% 125
2021
Q4 		– Sell
-245
Closed -$271K – 1958
2021
Q3 		$271K Buy
+245
New +$301K 0.02% 765
2020
Q3 		– Sell
-1,983
Closed -$2.36M – 1308
2020
Q2 		$2.36M Buy
+1,983
New +$1.72M 0.27% 73
2019
Q4 		$709K Buy
617
+231
+60% +$207K 0.07% 311
2019
Q3 		$238K Sell
386
-1,152
-75% -$957K 0.02% 876
2019
Q2 		$1.54M Buy
+1,538
New +$1.49M 0.09% 182
2019
Q1 		– Sell
-4,142
Closed -$2.72M – 1652
2018
Q4 		$2.72M Buy
4,142
+3,792
+1,083% +$3.98M 0.15% 91
2018
Q3 		$652K Buy
350
+207
+145% +$407K 0.04% 487
2018
Q2 		$271K Sell
143
-78
-35% -$137K 0.02% 1239
2018
Q1 		$351K Sell
221
-1,932
-90% -$3.6M 0.02% 936
2017
Q4 		$3.35M Buy
2,153
+141
+7% +$216K 0.18% 79
2017
Q3 		$3.44M Buy
2,012
+171
+9% +$237K 0.17% 64
2017
Q2 		$2.32M Sell
1,841
-3,883
-68% -$3.92M 0.32% 72
2017
Q1 		$5.46M Buy
+5,724
New +$5.1M 0.56% 27
2016
Q4 		– Sell
-2,450
Closed -$2.39M – 511
2016
Q3 		$2.39M Buy
2,450
+622
+34% +$513K 0.41% 48
2016
Q2 		$1.03M Sell
1,828
-829
-31% -$519K 0.14% 141
2016
Q1 		$1.46M Buy
2,657
+1,849
+229% +$1.17M 0.2% 116
2015
Q4 		$1.37M Buy
+808
New +$1.31M 0.19% 105

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Virtu Financial's LABU Position: Q4 2025 in Review

Virtu Financial sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2025, closing a stake of 18,769 shares — an estimated $1.76M sold.

Virtu Financial first reported a position in LABU in Q4 2015 and held it in 20 quarters. The position peaked at $5.46M in Q1 2017. 40 funds tracked by Wall St. Rank hold LABU as of Q4 2025.

  • Virtu Financial reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 18,769 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2025, an estimated $1.76M.
  • Virtu Financial first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2015 and held it in 20 quarters.
  • Virtu Financial's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.46M in Q1 2017.
  • 40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.